Akari Therapeutics PLC (AKTX)
1.36
-0.11
(-7.48%)
USD |
NASDAQ |
May 03, 16:00
1.39
+0.03
(+2.21%)
After-Hours: 20:00
Akari Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
DBV Technologies SA | -- |
Cellectis SA | 0.3968 |
Adaptimmune Therapeutics PLC | 0.00 |
Biodexa Pharmaceuticals Plc | 0.00 |
NuCana PLC | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 4.355M |
Total Liabilities (Quarterly) | 4.584M |
Shareholders Equity (Quarterly) | -0.229M |